Fibroblast growth factor receptor 2 phosphorylation on serine 779 couples to 14-3-3 and regulates cell survival and proliferation

Molecular and Cellular Biology

Volumn 28, Issue 10, 2008, Pages 3372-3385

  Lonic, Ana ^a   Barry, Emma F ^a   Quach, Cindy ^a   Kobe, Bostjan ^b   Saunders, Neil ^b   Guthridge, Mark A ^a,c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CELL SURFACE RECEPTOR; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 2; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE; PHOSPHOSERINE; RAS PROTEIN; SERINE;

ANIMAL CELL; ARTICLE; BINDING SITE; BIOLOGY; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOPLASM; EMBRYO; FIBROBLAST; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM;

14-3-3 PROTEINS; AMINO ACID SEQUENCE; ANIMALS; BALB 3T3 CELLS; BASE SEQUENCE; BINDING SITES; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; DNA, COMPLEMENTARY; FIBROBLAST GROWTH FACTOR 2; MICE; MUTAGENESIS, SITE-DIRECTED; PHOSPHORYLATION; PROTEIN KINASE C; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RECOMBINANT PROTEINS; SERINE; SIGNAL TRANSDUCTION;

EID: 43249088084     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01837-07     Document Type: Article

References (71)

1. Aitken, A. 2006. 14-3-3 proteins: a historic overview. Semin. Cancer Biol. 16:162-172.
2. Al-Hakim, A. K., O. Goransson, M. Deak, R. Toth, D. G. Campbell, N. A. Morrice, A. R. Prescott, and D. R. Alessi. 2005. 14-3-3 cooperates with LKB1 to regulate the activity and localization of QSK and SIK. J. Cell Sci. 118: 5661-5673.
3. Brinkworth, R. I., R. A. Breinl, and B. Kobe. 2003. Structural basis and prediction of substrate specificity in protein serine/threonine kinases. Proc. Natl. Acad. Sci. USA 100:74-79.
4. Craparo, A., R. Freund, and T. A. Gustafson. 1997. 14-3-3 (ε) interacts with the insulin-like growth factor I receptor and insulin receptor substrate I in a phosphoserine-dependent manner. J. Biol. Chem. 272:11663-11669.
5. Cross, M. J., M. N. Hodgkin, S. Roberts, E. Landgren, M. J. Wakelam, and L. Claesson-Welsh. 2000. Tyrosine 766 in the fibroblast growth factor receptor-1 is required for FGF-stimulation of phospholipase C, phospholipase D, phospholipase A(2), phosphoinositide 3-kinase and cytoskeletal reorganisation in porcine aortic endothelial cells. J. Cell Sci. 113:643-651.
6. Cross, M. J., L. Lu, P. Magnusson, D. Nyqvist, K. Holmqvist, M. Welsh, and L. Claesson-Welsh. 2002. The Shb adaptor protein binds to tyrosine 766 in the FGFR-1 and regulates the Ras/MEK/MAPK pathway via FRS2 phosphorylation in endothelial cells. Mol. Biol. Cell 13:2881-2893.
7. Dailey, L., D. Ambrosetti, A. Mansukhani, and C. Basilico. 2005. Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor Rev. 16:233-247.
8. Davies, S. P., H. Reddy, M. Caivano, and P. Cohen. 2000. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351:95-105.
9. Eswarakumar, V. P., I. Lax, and J. Schlessinger. 2005. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 16:139-149.
10. Fambrough, D., K. McClure, A. Kazlauskas, and E. S. Lander. 1999. Diverse signaling pathways activated by growth factor receptors induce broadly overlapping, rather than independent, sets of genes. Cell 97:727-741.
11. Fang, X., S. X. Yu, Y. Lu, R. C. Bast, Jr., J. R. Woodgett, and G. B. Mills. 2000. Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc. Natl. Acad. Sci. USA 97:11960-11965.
12. Foehr, E. D., S. Raffioni, J. Murray-Rust, and R. A. Bradshaw. 2001. The role of tyrosine residues in fibroblast growth factor receptor 1 signaling in PC12 cells. Systematic site-directed mutagenesis in the endodomain. J. Biol. Chem. 276:37529-37536.
13. Furdui, C. M., E. D. Lew, J. Schlessinger, and K. S. Anderson. 2006. Autophosphorylation of FGFR1 kinase is mediated by a sequential and precisely ordered reaction. Mol. Cell 21:711-717.
14. Glover, J. N., R. S. Williams, and M. S. Lee. 2004. Interactions between BRCT repeats and phosphoproteins: tangled up in two. Trends Biochem. Sci. 29:579-585.
15. Gottlieb, E., S. M. Armour, M. H. Harris, and C. B. Thompson. 2003. Mitochondrial membrane potential regulates matrix configuration and cytochrome c release during apoptosis. Cell Death Differ. 10:709-717.
16. Gray, A., J. Van Der Kaay, and C. P. Downes. 1999. The pleckstrin homology domains of protein kinase B and GRP1 (general receptor for phosphoinositides-1) are sensitive and selective probes for the cellular detection of phosphatidylinositol 3,4-bisphosphate and/or phosphatidylinositol 3,4,5-trisphosphate in vivo. Biochem. J. 344:929-936.
17. Guthridge, M. A., E. F. Barry, F. A. Felquer, B. J. McClure, F. C. Stomski, H. Ramshaw, and A. F. Lopez. 2004. The phosphoserine-585-dependent pathway of the GM-CSF/IL-3/IL-5 receptors mediates hematopoietic cell survival through activation of NF-κB and induction of bcl-2. Blood 103:820-827.
18. Guthridge, M. A., J. A. Powell, E. F. Barry, F. C. Stomski, B. J. McClure, H. Ramshaw, F. A. Felquer, M. Dottore, D. T. Thomas, B. To, C. G. Begley, and A. F. Lopez. 2006. Growth factor pleiotropy is controlled by a receptor Tyr/Ser motif that acts as a binary switch. EMBO J. 25:479-489.
19. Guthridge, M. A., F. C. Stomski, E. F. Barry, W. Winnall, J. M. Woodcock, B. J. McClure, M. Dottore, M. C. Berndt, and A. F. Lopez. 2000. Site-specific serine phosphorylation of the IL-3 receptor is required for hemopoietic cell survival. Mol. Cell 6:99-108.
20. Hadari, Y. R., N. Gotoh, H. Kouhara, I. Lax, and J. Schlessinger. 2001. Critical role for the docking-protein FRS2 alpha in FGF receptor-mediated signal transduction pathways. Proc. Natl. Acad. Sci. USA 98:8578-8583.
21. Hinsby, A. M., J. V. Olsen, and M. Mann. 2004. Tyrosine phosphoproteomics of fibroblast growth factor signaling: a role for insulin receptor substrate-4. J. Biol. Chem. 279:46438-46447.
22. Huang, J., M. Mohammadi, G. A. Rodrigues, and J. Schlessinger. 1995. Reduced activation of RAF-1 and MAP kinase by a fibroblast growth factor receptor mutant deficient in stimulation of phosphatidylinositol hydrolysis. J. Biol. Chem. 270:5065-5072.
23. Kouhara, H., Y. R. Hadari, T. Spivak-Kroizman, J. Schilling, D. Bar-Sagi, I. Lax, and J. Schlessinger. 1997. A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway. Cell 89:693-702.
24. Landgren, E., P. Klint, K. Yokote, and L. Claesson-Welsh. 1998. Fibroblast growth factor receptor-1 mediates Chemotaxis independently of direct SH2-domain protein binding. Oncogene 17:283-291.
25. Larsson, H., P. Klint, E. Landgren, and L. Claesson-Welsh. 1999. Fibroblast growth factor receptor-1-mediated endothelial cell proliferation is dependent on the Src homology (SH) 2/SH3 domain-containing adaptor protein Crk. J. Biol. Chem. 274:25726-25734.
26. Lin, H. Y., J. Xu, I. Ischenko, D. M. Ornitz, S. Halegoua, and M. J. Hayman. 1998. Identification of the cytoplasmic regions of fibroblast growth factor (FGF) receptor 1 which play important roles in induction of neurite outgrowth in PC12 cells by FGF-1. Mol. Cell. Biol. 18:3762-3770.
27. Lopez, M. E., and M. Korc. 2000. A novel type I fibroblast growth factor receptor activates mitogenic signaling in the absence of detectable tyrosine phosphorylation of FRS2. J. Biol. Chem. 275:15933-15939.
28. Lu, P. J., X. Z. Zhou, M. Shen, and K. P. Lu. 1999. Function of WW domains as phosphoserine- or phosphothreonine-binding modules. Science 283:1325-1328.
29. Lundin, L., L. Ronnstrand, M. Cross, C. Hellberg, U. Lindahl, and L. Claesson-Welsh. 2003. Differential tyrosine phosphorylation of fibroblast growth factor (FGF) receptor-1 and receptor proximal signal transduction in response to FGF-2 and heparin. Exp. Cell Res. 287:190-198.
30. Mackintosh, C. 2004. Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes. Biochem. J. 381:329-342.
31. Marshall, C. J. 1995. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179-185.
32. McGonigle, S., M. J. Beall, E. L. Feeney, and E. J. Pearce. 2001. Conserved role for 14-3-3ε downstream of type 1 TGFβ receptors. FEBS Lett. 490:65-69.
33. McGonigle, S., M. J. Beall, and E. J. Pearce. 2002. Eukaryotic initiation factor 2 alpha subunit associates with TGF beta receptors and 14-3-3 epsilon and acts as a modulator of the TGF beta response. Biochemistry 41:579-587.
34. Mohammadi, M., I. Dikic, A. Sorokin, W. H. Burgess, M. Jaye, and J. Schlessinger. 1996. Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction. Mol. Cell. Biol. 16:977-989.
35. Mohammadi, M., C. A. Dionne, W. Li, N. Li, T. Spivak, A. M. Honegger, M. Jaye, and J. Schlessinger. 1992. Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis. Nature 358: 681-684.
36. Mohammadi, M., A. M. Honegger, D. Rotin, R. Fischer, F. Bellot, W. Li, C. A. Dionne, M. Jaye, M. Rubinstein, and J. Schlessinger. 1991. A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-γ1. Mol. Cell. Biol. 11:5068-5078.
37. Mohammadi, M., S. K. Olsen, and O. A. Ibrahimi. 2005. Structural basis for fibroblast growth factor receptor activation. Cytokine Growth Factor Rev. 16:107-137.
38. Muslin, A. J., K. G. Peters, and L. T. Williams. 1994. Direct activation of phospholipase C-γ by fibroblast growth factor receptor is not required for mesoderm induction in Xenopus animal caps. Mol. Cell. Biol. 14:3006-3012.
39. Oksvold, M. P., H. S. Huitfeldt, and W. Y. Langdon. 2004. Identification of 14-3-3ζ as an EGF receptor interacting protein. FEBS Lett. 569:207-210.
40. Olayioye, M. A., M. A. Guthridge, F. C. Stomski, A. F. Lopez, J. E. Visvader, and G. J. Lindeman. 2003. Threonine 391 phosphorylation of the human prolactin receptor mediates a novel interaction with 14-3-3 proteins. J. Biol. Chem. 278:32929-32935.
41. Ong, S. H., Y. R. Hadari, N. Gotoh, G. R. Guy, J. Schlessinger, and I. Lax. 2001. Stimulation of phosphatidylinositol 3-kinase by fibroblast growth factor receptors is mediated by coordinated recruitment of multiple docking proteins. Proc. Natl. Acad. Sci. USA 98:6074-6079.
42. Ornitz, D. M., and P. Leder. 1992. Ligand specificity and heparin dependence of fibroblast growth factor receptors 1 and 3. J. Biol. Chem. 267: 16305-16311.
43. Pardo, O. E., C. Wellbrock, U. K. Khanzada, M. Aubert, I. Arozarena, S. Davidson, F. Bowen, P. J. Parker, V. V. Filonenko, I. T. Gout, N. Sebire, R. Marais, J. Downward, and M. J. Seckl. 2006. FGF-2 protects small cell lung cancer cells from apoptosis through a complex involving PKCε, B-Raf and S6K2. EMBO J. 25:3078-3088.
44. Partanen, J., L. Schwartz, and J. Rossant. 1998. Opposite phenotypes of hypomorphic and Y766 phosphorylation site mutations reveal a function for Fgfr1 in anteroposterior patterning of mouse embryos. Genes Dev. 12:2332-2344.
45. Pawson, T., G. D. Gish, and P. Nash. 2001. SH2 domains, interaction modules and cellular wiring. Trends Cell Biol. 11:504-511.
46. Pawson, T., and T. M. Saxton. 1999. Signaling networks - do all roads lead to the same genes? Cell 97:675-678.
47. Pearson, R. B., and B. E. Kemp. 1991. Protein kinase phosphorylation site sequences and consensus specificity motifs: tabulations. Methods Enzymol. 200:62-81.
48. Peruzzi, F., M. Prisco, M. Dews, P. Salomoni, E. Grassilli, G. Romano, B. Calabretta, and R. Baserga. 1999. Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Mol. Cell. Biol. 19:7203-7215.
49. 2+ flux but not mitogenesis. Nature 358:678-681.
50. Presta, M., P. Dell'Era, S. Mitola, E. Moroni, R. Ronca, and M. Rusnati. 2005. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev. 16:159-178.
51. Reilly, J. F., G. Mickey, and P. A. Maher. 2000. Association of fibroblast growth factor receptor 1 with the adaptor protein Grb14. Characterization of a new receptor binding partner. J. Biol. Chem. 275:7771-7778.
52. Santoro, M. M., G. Gaudino, and P. C. Marchisio. 2003. The MSP receptor regulates α6α4 and α3β1 integrins via 14-3-3 proteins in keratinocyte migration. Dev. Cell 5:257-271.
53. Santos, S. D., P. J. Verveer, and P. I. Bastiaens. 2007. Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate. Nat. Cell Biol. 9:324-330.
54. Schlessinger, J. 2000. Cell signaling by receptor tyrosine kinases. Cell 103: 211-225.
55. Schlessinger, J. 2004. Common and distinct elements in cellular signaling via EGF and FGF receptors. Science 306:1506-1507.
56. Simon, M. A. 2000. Receptor tyrosine kinases: specific outcomes from general signals. Cell 103:13-15.
57. Sliva, D., M. Gu, Y. X. Zhu, J. Chen, S. Tsai, X. Du, and Y. C. Yang. 2000. 14-3-3zeta interacts with the alpha-chain of human interleukin 9 receptor. Biochem. J. 345:741-747.
58. Songyang, Z., and L. C. Cantley. 2004. ZIP codes for delivering SH2 domains. Cell 116:S41-S43, 2 p. following S48.
59. Sorokin, A., M. Mohammadi, J. Huang, and J. Schlessinger. 1994. Internalization of fibroblast growth factor receptor is inhibited by a point mutation at tyrosine 766. J. Biol. Chem. 269:17056-17061.
60. Spivak-Kroizman, T., M. Mohammadi, P. Hu, M. Jaye, J. Schlessinger, and I. Lax. 1994. Point mutation in the fibroblast growth factor receptor eliminates phosphatidylinositol hydrolysis without affecting neuronal differentiation of PC12 cells. J. Biol. Chem. 269:14419-14423.
61. Staros, J. V. 1982. N-Hydroxysulfosuccinimide active esters: bis(N-hydroxysulfosuccinimide) esters of two dicarboxylic acids are hydrophilic, membrane-impermeant, protein cross-linkers. Biochemistry 21:3950-3955.
62. Stomski, F. C., M. Dottore, W. Winnall, M. A. Guthridge, J. Woodcock, C. J. Bagley, D. T. Thomas, R. K. Andrews, M. C. Berndt, and A. F. Lopez. 1999. Identification of a 14-3-3 binding sequence in the common beta chain of the granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), and IL-5 receptors that is serine-phosphorylated by GM-CSF. Blood 94:1933-1942.
63. Tallquist, M. D., W. J. French, and P. Soriano. 2003. Additive effects of PDGF receptor beta signaling pathways in vascular smooth muscle cell development. PLoS Biol. 1:E52.
64. Thisse, B., and C. Thisse. 2005. Functions and regulations of fibroblast growth factor signaling during embryonic development. Dev. Biol. 287:390-402.
65. Vander Heiden, M. G., D. R. Plas, J. C. Rathmell, C. J. Fox, M. H. Harris, and C. B. Thompson. 2001. Growth factors can influence cell growth and survival through effects on glucose metabolism. Mol. Cell. Biol. 21:5899-5912.
66. Wang, J. K., G. Gao, and M. Goldfarb. 1994. Fibroblast growth factor receptors have different signaling and mitogenic potentials. Mol. Cell. Biol. 14:181-188.
67. Wang, Q., Y. Zhou, and B. M. Evers. 2006. Neurotensin phosphorylates GSK-3α/β through the activation of PKC in human colon cancer cells. Neoplasia 8:781-787.
68. Waterman, M. J., E. S. Stavridi, J. L. Waterman, and T. D. Halazonetis. 1998. ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nat. Genet. 19:175-178.
69. Wu, J. W., M. Hu, J. Chai, J. Seoane, M. Huse, C. Li, D. J. Rigotti, S. Kyin, T. W. Muir, R. Fairman, J. Massague, and Y. Shi. 2001. Crystal structure of a phosphorylated Smad2. Recognition of phosphoserine by the MH2 domain and insights on Smad function in TGF-beta signaling. Mol. Cell 8:1277-1289.
70. Yaffe, M. B., and A. E. Elia. 2001. Phosphoserine/threonine- binding domains. Curr. Opin. Cell Biol. 13:131-138.
71. Yaffe, M. B., K. Rittinger, S. Volinia, P. R. Caron, A. Aitken, H. Leffers, S. J. Gamblin, S. J. Smerdon, and L. C. Cantley. 1997. The structural basis for 14-3-3:phosphopeptide binding specificity. Cell 91:961-971.